News | May 02, 2026
Merck posts mixed Q1 2026 results as blockbuster drugs drive growth
But acquisition charges drag earnings into loss
But acquisition charges drag earnings into loss
With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems
The company reported consolidated total income of Rs. 161.3 crore in Q4 FY26, a strong jump from Rs. 120.3 crore in the same period last year
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000
The new outpatient-focused clinic is designed to address voice, airway and swallowing disorders through advanced diagnostics
Paves the way for next-gen ultra-precise gas sensing
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
Subscribe To Our Newsletter & Stay Updated
